October found to be the optimum time to vaccinate against influenza

The optimum time to vaccinate young infants against influenza.

Pharmalittle: We’re reading about an Italian acquisition, Medicare Advantage market growth, and more

A pleasant Friday morning to you! Adam Feuerstein, here, reporting from the Pharmalittle campus, temporarily relocated to Cambridge, Mass., as your regular New Jersey host

October 4, 2024

Signal: Roche to refile subcutaneous Tecentriq with FDA after UK approval – Pharmaceutical Technology

Roche has pushed back the launch of its subcutaneous Tecentriq to 2024. Photo: Qilai Shen/Bloomberg via Getty Images. Pharmaceuticals giant Roche reportedly plans to file

September 13, 2023

Rucaparib camsylate by Pharmaand for Metastatic Biliary Tract Cancer: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.